Actively Recruiting
IMT in Asthma: Activity, Coping, Self-Management
Led by Istanbul Esenyurt University · Updated on 2026-01-09
15
Participants Needed
1
Research Sites
101 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to investigate asthma patients' experiences with an 8 week IMT and the perceived effects of this intervention on physical activity, coping strategies, and asthma self-management. A qualitative methodological design will be applied to understand the experiences of patients participating in the IMT program, how the program affected their daily activities, how they coped with symptoms and difficulties, and how they managed their condition.
CONDITIONS
Official Title
IMT in Asthma: Activity, Coping, Self-Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Being between the ages of 18-65
- Diagnosed with severe persistent, non-allergic asthma by a pulmonologist following GINA guidelines
- Presence of type 2 inflammation markers: peripheral eosinophils <150/µL and/or negative skin prick test and/or total IgE <30 kU/L
- Showing bronchodilator response (>12% or 200 mL improvement in FEV1% predicted after inhaling 400 mg salbutamol)
- Diagnosed at least 6 months prior and under follow-up and treatment or having controlled asthma
- Completed the pulmonary rehabilitation program
- Completed 8 weeks of inspiratory muscle training (IMT)
- Read, understood, and signed the informed consent form
You will not qualify if you...
- Recent respiratory tract infection within the last month
- Smoking history over 10 pack-years or smoking within 6 months after quitting
- Oral corticosteroid treatment in the last 4 weeks
- Body Mass Index greater than 35
- Diagnosed with Eosinophilic Granulomatosis Polyangiitis (EGPA) or Allergic Bronchopulmonary Aspergillosis (ABPA)
- Vasculitis
- History of malignancy
- Pregnancy
- Previous lung surgery or use of long-term oxygen therapy
- Presence of restrictive lung diseases (like advanced kyphoscoliosis, ankylosing spondylitis) or neuromuscular diseases (such as myasthenia gravis, muscular dystrophies, myopathies) preventing healthy respiratory testing and rehabilitation
- Cognitive dysfunction, mental retardation, dementia, or other conditions making protocol adherence difficult
- Unwillingness to continue participating
- Communication difficulties or intellectual disabilities
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istanbul Esenyurt University
Istanbul, Istanbul, Turkey (Türkiye), 34890
Actively Recruiting
Research Team
E
Esra PEHLİVAN, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here